11-59151801-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001312909.2(FAM111A):c.133T>A(p.Ser45Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,612,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001312909.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM111A | NM_001312909.2 | c.133T>A | p.Ser45Thr | missense_variant | 6/6 | ENST00000675163.1 | NP_001299838.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM111A | ENST00000675163.1 | c.133T>A | p.Ser45Thr | missense_variant | 6/6 | NM_001312909.2 | ENSP00000501952.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151860Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250500Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135422
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461002Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726820
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151860Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74144
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.133T>A (p.S45T) alteration is located in exon 5 (coding exon 2) of the FAM111A gene. This alteration results from a T to A substitution at nucleotide position 133, causing the serine (S) at amino acid position 45 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 26, 2022 | This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 45 of the FAM111A protein (p.Ser45Thr). This variant is present in population databases (rs369963232, gnomAD 0.05%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FAM111A-related conditions. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at